Chronic Underperformer Aviva plc Could Be My Next Sell

Aviva plc (LON:AV) may be making a short-term recovery, but its long-term track record is dire, and recent trading results contain some red flags, says Roland Head.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Here at the Fool, we advocate the idea of long-term investing, and by and large this approach is pretty successful — but there are exceptions, and accident-prone insurer Aviva (LSE: AV) (NYSE: AV.US) is definitely one of them.

If you’d invested £10,000 in a FTSE 100 tracker 25 years ago, in November 1988, it would be worth around £37,000 today, without dividends.

If you’d invested the same £10,000 in Aviva’s predecessors 25 years ago, it would be worth just £12,400, excluding dividends.

Aviva’s dividends haven’t made up for the long-term pain, either, as the firm is a repeat offender when it comes to dividend cuts, as these figures show:

Year Percentage dividend cut
1994 -33%
2002 -14%
2003 -28%
2009 -15%
2013 -43%

It’s not a very impressive record for income investors, especially when you compare it to peer Legal & General, whose dividend has tripled over the same period.

Of course, most of this is ancient history, isn’t it? Aviva’s share price has risen by 23% over the last year, comfortably outperforming the FTSE 100, and the firm’s shares still offer a reasonable 3.4% yield.

What’s more, Aviva’s new CEO, Mark Wilson, is doing an impressive job of refocusing the company and improving cash flow, and the firm recently confirmed the $2.6bn sale of its US business, strengthening its balance sheet still further.

What could possibly go wrong?

As a shareholder, I hate to say it, but there are a few clouds on the horizon.

The value of Aviva’s new life insurance and pension sales fell by 5% during the third quarter, while its long-term savings sales fell by 2%. Investment sales were up by 9% — as you’d expect with a booming stock market — but this trend could easily reverse if the FTSE undergoes a correction over the next few months.

Aviva’s £8.4bn UK property portfolio isn’t all that healthy, either. According to the firm’s 2013 interim results, it currently has £1.3bn of negative equity at current property prices, and a further £1.6bn of loans where the loan-to-value ratio is between 95% and 100%.

These risky loans were made before the financial crisis, but many of them relate to retail property in the north of England, where property prices haven’t rebounded as they have in the south — so there is no guarantee that Aviva’s negative equity problems won’t get worse.

Sell Aviva?

Aviva’s current property problems aren’t unique in the UK market, and in my view, the company’s medium-term prospects are quite good. 

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

> Roland owns shares in Aviva but not in any of the other companies mentioned in this article.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »